Efficacy and Safety of Gefitinib Plus Anlotinib for Patients with EGFR Positive Advanced Non-Small-Cell Lung Cancer: A Retrospective Exploratory Study

Efficacy and Safety of Gefitinib Plus Anlotinib for Patients with EGFR Positive Advanced Non-Small-Cell Lung Cancer: A Retrospective Exploratory Study

Wen-Xia Hu, Jing-Cui Peng, Yun Wang, Hao Jin, Nan Geng Department of Respiratory Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050012, People’s Republic of ChinaCorrespondence: Nan Geng, Department of Respiratory Medicine, The Fourth Hospital of Hebei Medical University, 1...

Full description

Bibliographic Details
Main Authors: Hu WX, Peng JC, Wang Y, Jin H, Geng N
Format: Article
Language:English
Published: Dove Medical Press 2022-04-01
Series:International Journal of General Medicine
Subjects:
non-small cell lung cancer
egfr mutation
anlotinib
gefitinib
efficacy
safety
Online Access:https://www.dovepress.com/efficacy-and-safety-of-gefitinib-plus-anlotinib-for-patients-with-egfr-peer-reviewed-fulltext-article-IJGM

Internet

https://www.dovepress.com/efficacy-and-safety-of-gefitinib-plus-anlotinib-for-patients-with-egfr-peer-reviewed-fulltext-article-IJGM

Similar Items